Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oskar W Rokhlin

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Cellular Biochemistry|December 31, 2008
Mechanisms of prostate cancer cell survival after inhibition of AR expressionMichael B Cohen, Oskar W Rokhlin
Cancer Biology & Therapy|July 25, 2003
Bisindolylmaleimide IX Induces Reversible and Time-Dependent Tumor Necrosis Factor Receptor Family-Mediated Caspase Activation and Cell DeathOskar W Rokhlin, Michael B Cohen
Genes & Cancer|December 31, 2011
Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaPAgshin F Taghiyev, Oskar W Rokhlin, Rebecca B Glover
Journal of Cellular Biochemistry|December 23, 2003
Death receptor-induced cell death in prostate cancerNatalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Journal of Drug Targeting|August 8, 2008
Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitroRishikesh M Sawant, Michael B Cohen, Vladimir P Torchilin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2008
Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosisAndrei P Komarov, Oskar W Rokhlin, Chang-An Yu, et al.
The Prostate|May 3, 2002
Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3Natalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Breast Cancer Research and Treatment|April 25, 2007
Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L)Natalya V Guseva, Oskar W Rokhlin, Agshin F Taghiyev, et al.
Cancer Biology & Therapy|March 13, 2012
P53 and the proteasome regulate androgen receptor activityNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Cancer Biology & Therapy|April 29, 2011
TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 statusNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Cellular Biochemistry|December 31, 2008
Mechanisms of prostate cancer cell survival after inhibition of AR expressionMichael B Cohen, Oskar W Rokhlin
Cancer Biology & Therapy|July 25, 2003
Bisindolylmaleimide IX Induces Reversible and Time-Dependent Tumor Necrosis Factor Receptor Family-Mediated Caspase Activation and Cell DeathOskar W Rokhlin, Michael B Cohen
Genes & Cancer|December 31, 2011
Caspase-2-Based Regulation of the Androgen Receptor and Cell Cycle in the Prostate Cancer Cell Line LNCaPAgshin F Taghiyev, Oskar W Rokhlin, Rebecca B Glover
Journal of Cellular Biochemistry|December 23, 2003
Death receptor-induced cell death in prostate cancerNatalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Journal of Drug Targeting|August 8, 2008
Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitroRishikesh M Sawant, Michael B Cohen, Vladimir P Torchilin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2008
Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosisAndrei P Komarov, Oskar W Rokhlin, Chang-An Yu, et al.
The Prostate|May 3, 2002
Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3Natalya V Guseva, Agshin F Taghiyev, Oskar W Rokhlin, et al.
Breast Cancer Research and Treatment|April 25, 2007
Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L)Natalya V Guseva, Oskar W Rokhlin, Agshin F Taghiyev, et al.
Cancer Biology & Therapy|March 13, 2012
P53 and the proteasome regulate androgen receptor activityNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Cancer Biology & Therapy|April 29, 2011
TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 statusNatalya V Guseva, Oskar W Rokhlin, Rebecca A Glover, et al.
Pageof 3